Table 1.
ES cells: DNA damage: | Control No | Rad21 ko (24h) No | |
---|---|---|---|
ES cell # | 100×106 | 100×106 | |
Somatic cell # | 100×106 | 100×106 | |
Heterokaryon # | ∼6×106* | ∼6×106* | |
Reprogramming |
++ |
+++ |
|
ES cells: DNA damage: |
Control No |
Rad 21 ko (48h) Incidental |
Doxorubicin Deliberate |
ES cell # | 25×106 | 25×106 | 25×106 |
Somatic cell # | 25×106 | 25×106 | 25×106 |
Heterokaryon # | ∼1.5×106* | None | None |
Reprogramming | ++ | N/A | N/A |
Estimate based on 3% fusion efficiency determined by flow cytometry
Acutely cohesin-depleted ES cells not only retained the ability to reprogram somatic cells in heterokaryons but in addition showed an unexpected increase in their reprogramming potential (top, n = 3 biological replicates, 100 × 106 ES cells per fusion). 41 Fusion with Rad21 KO (48h) ES cells and doxorubicin-treated (6h) ES cells did not result in viable heterokaryon formation or reprogramming. Poor survival meant that lower ES cell numbers were available (25 × 106), and control ES cell numbers were reduced accordingly (bottom, n=2 biological replicates per treatment condition).